By the WoundSource Editors
Largo, FL – February 26, 2015 – ManukaMed USA has successfully launched an improved version of its of Manukahd lite dressings.
The dressings improve exudate management through high levels of active absorption of wound exudate, while providing maximum exposure to a high purity medical grade leptospermum scoparium (Manuka) honey.
Laboratory research conducted exclusively by ManukaMed at universities and research institutes around the world, has led to a greater understanding of the critical bioactive components within the honey and improvements include proprietary modifications to the way Manuka honey is impregnated into the super absorbent gelling fiber (SAF) along with the highest standard of testing and qualification QBTA (Quality Bioactive Testing Assurance) of the honey to ensure improved and consistent clinical results.
Recently (January 29, 2015) PDAC (Medicare Pricing, Data Analysis and Coding) verified that Manukahd lite dressings are assigned HCPCS codes consistent with A6196, A6197 and A6199. As of this date there are no other honey based wound dressings assigned with HCPCS coding. The positive coding results will allow clinicians to start therapy with Manukamed honey dressings and stay with this throughout the patient’s course of treatment as part of a comprehensive wound care protocol.
The ManukaMed porfolio of advanced wound care dressings includes Manukahd, Manukahd lite, Manukatex and Manukapli.
For more information, visit www.manukamed.com.